News

Even low doses of CBD may cause harm to the liver in some people, FDA study finds
From capsules, gummies and other edibles, to oils and lotions, CBD products have become increasingly popular in the United ...
Opinion
FDA should judge drugs on what they do in real life, not just in companies’ clinical trials
Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...
'Vietnam was insane, Apocalypse Now only slightly less so': The inside story of the wildest shoot in film history
No production has been as troubled as Apocalypse Now. As a documentary about Francis Ford Coppola's 1979 war epic is ...
Top FDA vaccine official rejected broad use of Covid-19 shots, documents show
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
Targeted Oncology18h
FDA Approves SIR-Spheres Y-90 for First-Line Use in Unresectable HCC
The FDA approves SIR-Spheres Y-90 microspheres for treating unresectable hepatocellular carcinoma, showcasing impressive ...
Weight loss drug Wegovy: The pros and cons, explained
The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...
Inside the Collapse of the F.D.A.
Jeneen Interlandi, a domestic correspondent for Opinion and a staff writer at the magazine, writes frequently about public health. For this article, she interviewed dozens of people who have worked ...
Eli Lilly's 3-step strategy to dominate the $95 billion obesity market
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Harris English's caddie is denied a UK visa over his past drug conviction
His caddie, Eric Larson, is stuck at home without being able to obtain a new Electronic Travel Authority visa for travel to ...
Johnson & Johnson: Supplemental new drug application submitted to U.S. FDA for CAPLYTA (lumateperone) with data demonstrating significant schizophrenia relapse prevention ...
Submission is based on long-term Phase 3 data demonstrating 63 percent reduction in risk of relapse in adults with schizophrenia compared to placebo CAPLYTA® is FDA ...